Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifluoperazine in Diamond Blackfan Anemia
NCT03966053Phase 2Terminated
- Start
- Sep 2019
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
A Phase 2 trial of trifluoperazine in Diamond-Blackfan anemia (DBA), pure red cell aplasia (PRCA). Started Sep 2019; status: terminated.
02
Drugs
trifluoperazine
03
Conditions
Diamond-Blackfan anemia (DBA)pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT03966053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03966053.